Christian Kirisits
Overview
Explore the profile of Christian Kirisits including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
165
Citations
5154
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Schmid M, Petric P, Mahantshetty U, Kirisits C, Tanderup K, Jurgenliemk-Schulz I, et al.
Lancet
. 2024 Nov;
404(10467):2050-2051.
PMID: 39580199
No abstract available.
2.
Lindegaard J, Petric P, Tan L, Hoskin P, Schmid M, Jurgenliemk-Schulz I, et al.
Int J Gynecol Cancer
. 2024 Jul;
34(12):1940-1945.
PMID: 38986568
Major improvements in radiotherapy over the past two decades in the definitive treatment of locally advanced cervical cancer have significantly improved loco-regional control and survival, whereas little progress has been...
3.
Moll M, Magrowski L, Mittlbock M, Heinzl H, Kirisits C, Ciepal J, et al.
Strahlenther Onkol
. 2024 Jun;
201(1):11-19.
PMID: 38829436
Purpose: External beam radiotherapy (EBRT) with or without brachytherapy boost (BTB) has not been compared in prospective studies using guideline-recommended radiation dose and recommended androgen-deprivation therapy (ADT). In this multicenter...
4.
Chen Z, Li X, Brenner D, Hellebust T, Hoskin P, Joiner M, et al.
Med Phys
. 2024 May;
51(6):3850-3923.
PMID: 38721942
Brachytherapy utilizes a multitude of radioactive sources and treatment techniques that often exhibit widely different spatial and temporal dose delivery patterns. Biophysical models, capable of modeling the key interacting effects...
5.
Moll M, Nechvile E, Kirisits C, Komina O, Pajer T, Kohl B, et al.
Strahlenther Onkol
. 2024 Mar;
200(8):698-705.
PMID: 38488901
Background And Purpose: Comparing oncological outcomes and toxicity after primary treatment of localized prostate cancer using HDR- or LDR-mono-brachytherapy (BT), or conventionally (CF) or moderately hypofractionated (HF) external beam radiotherapy....
6.
Ecker S, Kirisits C, Schmid M, Knoth J, Heilemann G, De Leeuw A, et al.
Radiother Oncol
. 2023 Jun;
186:109748.
PMID: 37330055
Purpose: To develop a novel decision-support system for radiation oncology that incorporates clinical, treatment and outcome data, as well as outcome models from a large clinical trial on magnetic resonance...
7.
Dizendorf E, Sturdza A, Tagliaferri L, Russo L, Nesvacil N, Kirisits C
Brachytherapy
. 2023 Feb;
22(3):343-351.
PMID: 36828765
Purpose: To provide educational support to brachytherapy users during the COVID-19 pandemic, online workshops were developed and implemented by BrachyAcademy, non-profit peer-to-peer educational initiative in Elekta. Methods And Materials: In...
8.
Annede P, Ferre M, Kirisits C, Pieters B, Schmid M, Strnad V, et al.
Clin Transl Radiat Oncol
. 2023 Feb;
39:100589.
PMID: 36785565
Purpose: A meta-analysis is presented comparing clinical outcomes and toxicities between high dose rate (HDR) and pulsed dose rate (PDR) brachytherapy (BT) for anal cancer. Methods And Material: Retrospective or...
9.
Ecker S, Kirisits C, Schmid M, De Leeuw A, Seppenwoolde Y, Knoth J, et al.
Radiother Oncol
. 2023 Feb;
182:109524.
PMID: 36764459
Purpose: To develop and implement a software that enables centers, treating patients with state-of-the-art radiation oncology, to compare their patient, treatment, and outcome data to a reference cohort, and to...
10.
Vittrup A, Kirchheiner K, Potter R, Fokdal L, Jensen N, Spampinato S, et al.
Int J Radiat Oncol Biol Phys
. 2023 Jan;
116(4):807-824.
PMID: 36641039
Purpose: To evaluate overall severe late morbidity (grade ≥3) in patients with locally advanced cervical cancer treated with chemo-radiation therapy and magnetic resonance image guided adaptive brachytherapy within the prospective...